search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

Prostate cancer reactivates developmental epigenomic programs during metastatic progression.

Mark M Pomerantz ,
Xintao Qiu ,
Yanyun Zhu ,
David Y Takeda ,
Wenting Pan ,
Sylvan C Baca ,
Alexander Gusev ,
Keegan D Korthauer ,
Tesa M Severson ,
Gavin Ha ,
Srinivas R Viswanathan ,
Ji-Heui Seo ,
Holly M Nguyen ,
Baohui Zhang ,
Bogdan Pasaniuc ,
Claudia Giambartolomei ,
Sarah A Alaiwi ,
Connor A Bell ,
Edward P O'Connor ,
Matthew S Chabot ,
David R Stillman ,
Rosina Lis ,
Alba Font-Tello ,
Lewyn Li ,
Paloma Cejas ,
Andries M Bergman ,
Joyce Sanders ,
Henk G van der Poel ,
Simon A Gayther ,
Kate Lawrenson ,
Marcos A S Fonseca ,
Jessica Reddy ,
Rosario I Corona ,
Gleb Martovetsky ,
Brian Egan ,
Toni Choueiri ,
Leigh Ellis ,
Isla P Garraway ,
Gwo-Shu Mary Lee ,
Eva Corey ,
Henry W Long ,
Wilbert Zwart ,
Matthew L Freedman

Abstract

Epigenetic processes govern prostate cancer (PCa) biology, as evidenced by the dependency of PCa cells on the androgen receptor (AR), a prostate master transcription factor. We generated 268 epigenomic datasets spanning two state transitions-from normal prostate epithelium to localized PCa to metastases-in specimens derived from human tissue. We discovered that reprogrammed AR sites in metastatic PCa are not created de novo; rather, they are prepopulated by the transcription factors FOXA1 and HOXB13 in normal prostate epithelium. Reprogrammed regulatory elements commissioned in metastatic disease hijack latent developmental programs, accessing sites that are implicated in prostate organogenesis. Analysis of reactivated regulatory elements enabled the identification and functional validation of previously unknown metastasis-specific enhancers at HOXB13, FOXA1 and NKX3-1. Finally, we observed that prostate lineage-specific regulatory elements were strongly associated with PCa risk heritability and somatic mutation density. Examining prostate biology through an epigenomic lens is fundamental for understanding the mechanisms underlying tumor progression.

More about this publication

Nature genetics

Volume 52
Issue nr. 8
Pages 790-799
Publication date 01-08-2020

Full text links

Publisher website (DOI) 10.1038/s41588-020-0664-8
Europe PubMed Central 32690948
Pubmed 32690948

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.